Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182


Current and emerging therapies for the treatment of osteoporosis.

Waalen J.

J Exp Pharmacol. 2010 Aug 27;2:121-34. doi: 10.2147/JEP.S7823. Review.


The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?

Bassuk SS, Manson JE.

Metabolism. 2016 May;65(5):794-803. doi: 10.1016/j.metabol.2016.01.004. Review.


Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.

Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL; Ovarian Cancer Association Consortium..

Obstet Gynecol. 2016 May;127(5):828-36. doi: 10.1097/AOG.0000000000001387.


Comparative effectiveness research and its utility in In-clinic practice.

Dang A, Kaur K.

Perspect Clin Res. 2016 Jan-Mar;7(1):9-14. doi: 10.4103/2229-3485.173780. Review.


Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Engler-Chiurazzi EB, Brown CM, Povroznik JM, Simpkins JW.

Prog Neurobiol. 2016 Feb 15. pii: S0301-0082(15)30063-0. doi: 10.1016/j.pneurobio.2015.12.008. Review.


Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.

Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JE.

J Natl Cancer Inst. 2016 Mar;108(3). pii: djv350. doi: 10.1093/jnci/djv350.


Towards understanding the de-adoption of low-value clinical practices: a scoping review.

Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, Stelfox HT.

BMC Med. 2015 Oct 6;13:255. doi: 10.1186/s12916-015-0488-z. Review.


Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border.

Gomes T, Paterson JM, Mukati M, Henry D; Canadian Network for Observational Drug Effect Studies investigators..

CMAJ Open. 2015 Apr 2;3(2):E231-5. doi: 10.9778/cmajo.20140103.


Discovering Multi-Scale Co-Occurrence Patterns of Asthma and Influenza with Oak Ridge Bio-Surveillance Toolkit.

Ramanathan A, Pullum LL, Hobson TC, Stahl CG, Steed CA, Quinn SP, Chennubhotla CS, Valkova S.

Front Public Health. 2015 Aug 3;3:182. doi: 10.3389/fpubh.2015.00182.


Estrogen and Cardiovascular Disease: Is Timing Everything?

Giordano S, Hage FG, Xing D, Chen YF, Allon S, Chen C, Oparil S.

Am J Med Sci. 2015 Jul;350(1):27-35. doi: 10.1097/MAJ.0000000000000512. Review. No abstract available.


Testing the Critical Window Hypothesis of Timing and Duration of Estradiol Treatment on Hypothalamic Gene Networks in Reproductively Mature and Aging Female Rats.

Yin W, Maguire SM, Pham B, Garcia AN, Dang NV, Liang J, Wolfe A, Hofmann HA, Gore AC.

Endocrinology. 2015 Aug;156(8):2918-33. doi: 10.1210/en.2015-1032.


Menopausal hormone therapy and breast cancer mortality: clinical implications.

Chlebowski RT, Anderson GL.

Ther Adv Drug Saf. 2015 Apr;6(2):45-56. doi: 10.1177/2042098614568300. Review.


Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use.

Daubresse M, Hutfless S, Kim Y, Kornfield R, Qato DM, Huang J, Miller K, Emery SL, Alexander GC.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):40-6. doi: 10.1164/rccm.201409-1585OC.


Economics and industry do not mean ethical conduct in clinical trials.

Lexchin J.

J Pharm Policy Pract. 2013 Dec 2;6:11. doi: 10.1186/2052-3211-6-11.


Long-term health consequences of premature or early menopause and considerations for management.

Faubion SS, Kuhle CL, Shuster LT, Rocca WA.

Climacteric. 2015;18(4):483-91. doi: 10.3109/13697137.2015.1020484. Review.


Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.

Fishman JR, Flatt MA, Settersten RA Jr.

Soc Sci Med. 2015 May;132:79-87. doi: 10.1016/j.socscimed.2015.02.027.


A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.

Drewe J, Bucher KA, Zahner C.

Springerplus. 2015 Feb 10;4:65. doi: 10.1186/s40064-015-0808-y.


Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study.

Lee E, Luo J, Su YC, Lewinger JP, Schumacher FR, Van Den Berg D, Wu AH, Bernstein L, Ursin G.

Breast Cancer Res. 2014 Dec 11;16(6):477. doi: 10.1186/s13058-014-0477-8.


Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA.

Bone. 2015 Apr;73:1-7. doi: 10.1016/j.bone.2014.12.003.

Items per page

Supplemental Content

Support Center